China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Survival Analysis of Surgical Resection Versus Observation in Patients with Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response After Systemic Therapy: A Multicenter, Real-World Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133059
Registration Time: 2026/09/21
Type: Observational study
Primary Sponsor: Fuzhou University Affiliated Provincial Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=297293
Published by HT Digital Content Services with permission from Health Daily Digest....